Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair.

Today Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors ensures Truveta is operating in pursuit of its mission, providing strategic, scientific, and operational direction.

With Providence as a founding health system member, Dr. Hochman was instrumental to the formation of Truveta in 2020. Dr. Hochman has continued to provide strategic guidance and supported Truveta’s growth over the years.

Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair.

“Formed and led by health systems, the leadership from our Board of Directors is essential for Truveta to deliver on our shared mission of Saving Lives with Data,” said Terry Myerson, CEO, Truveta. “Dr. Hochman has been foundational to Truveta growing into the company it is today and shares our big dreams for its future. Today we are thrilled to welcome him to our Board of Directors, where his leadership can help us continue to advance discovery and innovation across health systems, life sciences, government, and academic research organizations to improve care for all.”

As president and CEO of Providence, Dr. Hochman is responsible for leading the seven-state health system, ensuring access to high-quality, compassionate care is available in each of the communities Providence serves. Dr. Hochman has served as chair of the American Hospital Association in 2021 and is a former chair of the Catholic Health Association’s board of trustees.

Prior to serving as CEO of Providence, Dr. Hochman led Swedish Health Services, among one of the system’s family of organizations.

Earlier in his career, he served as a senior executive for Sentara Healthcare, the Health Alliance of Greater Cincinnati and for Guthrie Health System. He received his bachelor’s and medical degrees from Boston University and served as a clinical Fellow in internal medicine at Harvard Medical School and Dartmouth Medical School. In addition, he is a Fellow of the American College of Physicians and of the American College of Rheumatology.